L. Vallejo-Aparicio, J. Molina, I. Ojanguren, A. Viejo Casas, A. Huerta, H. Svedsater
{"title":"更正:在西班牙,糠酸氟替卡松/维兰特罗用于哮喘治疗的成本-后果分析:基于哮喘索尔福德肺部研究的分析","authors":"L. Vallejo-Aparicio, J. Molina, I. Ojanguren, A. Viejo Casas, A. Huerta, H. Svedsater","doi":"10.1007/s10198-019-01137-z","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":22450,"journal":{"name":"The European Journal of Health Economics","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Correction to: Cost–consequence analysis of fluticasone furoate/vilanterol for asthma management in Spain: an analysis based on the Salford Lung Study in asthma\",\"authors\":\"L. Vallejo-Aparicio, J. Molina, I. Ojanguren, A. Viejo Casas, A. Huerta, H. Svedsater\",\"doi\":\"10.1007/s10198-019-01137-z\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":22450,\"journal\":{\"name\":\"The European Journal of Health Economics\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-12-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The European Journal of Health Economics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s10198-019-01137-z\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The European Journal of Health Economics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s10198-019-01137-z","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Correction to: Cost–consequence analysis of fluticasone furoate/vilanterol for asthma management in Spain: an analysis based on the Salford Lung Study in asthma